Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals

Journal of Hospital Infection

Volumn 82, Issue 2, 2012, Pages 85-93

  Khan, A S ^a,b   Dancer, S J ^c   Humphreys, H ^a,b  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c HAIRMYRES HOSPITAL   (United Kingdom)

Author keywords

Carbapenem resistance; Escherichia coli; Extended spectrum beta lactamases; Hygiene; Klebsiella pneumoniae; Screening

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAND WASHING; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANT ENTEROBACTERIACEAE; NONHUMAN; PATIENT CARE; REVIEW; SCREENING; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFECTION CONTROL;

EID: 84866360123     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.06.013     Document Type: Review

References (131)

1. Pitout J.D.D., Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
2. Falagas M.E., Karageorgopoulos D.E. Extended-spectrum β-lactamase-producing organisms. J Hosp Infect 2009, 73:345-354.
3. Cantón R., Akóva M., Carmeli Y., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012, 18:413-431.
4. Nordmann P., Poirel L., Toleman M.A., Walsh T.R. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?. J Antimicrob Chemother 2011, 66:689-692.
5. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9:228-236.
6. Paterson D.L., Doi Y. A step closer to extreme drug resistance (XDR) in Gram-negative bacilli. Clin Infect Dis 2007, 45:1179-1181.
7. Magiorkos A.-P., Srinivasan A., Carey R.B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
8. Willemsen I., Elberts S., Verhulst C., et al. Highly resistant Gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (Triangle Study). Infect Control Hosp Epidemiol 2011, 32:333-341.
9. Nicolas-Chamoine M.H., Jarlier V. Extended-spectrum β-lactamases in long-term-care facilities. Clin Microbiol Infect 2008, 14(Suppl. 1):111-116.
10. Urban C., Bradford P.A., Tuckman M., et al. Carbapenem-resistant Escherichia coli harbouring Klebsiella pneumoniae carbapenemase β-lactamases associated with long-term facilities. Clin Infect Dis 2008, 46:e127-e130.
11. Carattoli A. Animal reservoirs for extended spectrum β-lactamase producers. Clin Microbiol Infect 2008, 14(Suppl. 1):117-223.
12. Warren R.E., Ensor V.M., O'Neill P., et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK. J Antimicrob Chem 2008, 61:504-508.
13. Galvin S., Boyle F., Hickey P., Vellinga A., Morris D., Cormican M. Enumeration and characterisation of antimicrobial-resistant Escherichia coli bacteria in effluent from municipal, hospital, and secondary treatment facility resources. Appl Environ Microbiol 2010, 76:4772-4779.
14. Chagas T.P.G., Seki L.M., da Silva D.M., Asensi M.D. Occurrence of KPC-2-producing Klebsiella pneumoniae strains in hospital wastewater. J Hosp Infect 2011, 77:281-282.
15. Dancer S.J. 'How antibiotics can make us sick.' Review of the lesser-known adverse effects of antibiotic chemotherapy. Lancet Infect Dis 2004, 4:611-619.
16. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130.
17. Touati A., Brasme L., Benallaoua S., Madoux J., Gharout A., de Champs C. Enterobacter cloacae and Klebsiella pneumoniae isolates producing CTX-M-15 recovered from hospital environmental surfaces from Algeria. J Hosp Infect 2008, 68:183-185.
18. Kac G., Podglajen I., Vaupré S., Colardelle N., Buu-Hof A., Gutmann L. Molecular epidemiology of extended spectrum beta-lactamase producing Enterobacteriaceae isolated from environmental and clinical specimens in a cardiac surgery intensive care unit. Infect Control Hosp Epidemiol 2004, 10:852-855.
19. D'agata E.M., Venkataraman L., DeGirolami P., Samore M. Molecular epidemiology of ceftazidime-resistant Gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods. J Clin Microbiol 1999, 37:3065-3067.
20. Getchell-White S.I., Donowitz L.G., Groschel D.H. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter caloaceticus. Infect Control Hosp Epidemiol 1989, 10:402-407.
21. Lemmen S.W., Hafner H., Zolldan D., Stanzel S., Lutticken R. Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment. J Hosp Infect 2004, 56:191-197.
22. Dancer S.J., Coyne M., Robertson C., Thomson A., Guleri A., Alcock S. Environmental organisms from hospital wards with differing antibiotic exposure. J Hosp Infect 2006, 62:200-206.
23. Guet-Revillet H., Le Monnier A., Breton N., et al. Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp?. Am J Infect Control 2012 Feb 9, [Epub ahead of print].
24. Nseir S., Blazejewski C., Lubret R., Wallet F., Courcol R., Durocher A. Risk of acquiring multi-drug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2010, 17:1201-1208.
25. Wilks M., Wilson A., Warwick S., et al. Control of an outbreak of multidrug-resistant Acinetobacter baumannii calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006, 27:654-658.
26. Dancer S.J., Carling P.C. All that glistens may be neither gold nor clean. J Hosp Infect 2010, 76:177-178.
27. Hobson R.P., MacKenzie F.M., Gould I.M. An outbreak of multiply-resistant Klebsiella pneuomiae in the Grampian region of Scotland. J Hosp Infect 1996, 33:249-262.
28. Costerton J.W., Cheng K.-J., Geesey G.G., et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987, 41:435-464.
29. Yang D., Zhang Z. Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum β-lactamases. J Hosp Infect 2008, 68:369-371.
30. Vickery K., Deva A., Jacombs A., Allan J., Valente P., Gosbell I.B. Presence of biofilm containing viable multi-resistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect 2012, 80:52-55.
31. Souli M., Galani I., Antoniadou A., et al. An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterisation, epidemiology and outcomes. Clin Infect Dis 2010, 50:364-373.
32. Rottier W.C., Ammerlaan H.S.M., Bonten M.J.M. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome; a meta-analysis. J Antimicrob Chemother 2012, 67:1311-1320.
33. Marchaim D., Gottesman T., Schwartz O., et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 2010, 54:5099-5104.
34. Qureshi Z.A., Paterson D.L., Pakstis D.L., et al. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents 2011, 37:26-32.
35. Falcone M., Mezzatesta M.L., Perilli M., et al. Infections with VIM-1 metallo-β-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome. J Clin Microbiol 2009, 47:3514-3519.
36. Nguyen M., Eschenauer G.A., Bryan M., et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis 2010, 67:180-184.
37. Croxall G., Hale J., Weston V., et al. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 2011, 66:2501-2508.
38. Lledo W., Hernandez M., Lopez E., et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Morb Mortal Wkly Rev 2009, 58:256-260.
39. Carmeli Y., Akova M., Cornaglia G., et al. Controlling the spread of carbapenemase-producing Gram negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010, 16:102-111.
40. Mattner F., Bange F.C., Meyer E., Seifert H., Wichelhaus T.A., Chaberny I.F. Preventing the spread of multidrug resistant gram-negative pathogens: recommendations of an expert panel of the German Society of Hygiene and Microbiology. Dtsch Arzbtebl Int 2012, 108:39-45.
41. Harris A.D., Perencevich E.N., Johnson J.K., et al. Patient-to-patient transmission is important in extended-spectrum-producing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007, 45:1347-1350.
42. Harris A.D., Kotetishvili M., Shurland S., et al. How important is patient-to-patient transmission in extended-spectrum β-lactamase Escherichia coli acquisition?. Am J Infect Control 2007, 35:97-101.
43. Fankhauser C., Zingg W., Francois P., et al. Surveillance of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a Swiss tertiary care hospital. Swiss Med Wkly 2009, 139:747-751.
44. Cohen M.J., Anshelevich O., Raveh D., Broide E., Rudensky B., Yinnon A.M. Acquisition of multidrug-resistant organisms among hospital patients hospitalized in beds adjacent to critically ill patients. Infect Control Hosp Epidemiol 2006, 27:675-681.
45. Kochar S., Sheard T., Sharma R., et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009, 30:447-452.
46. Calfee D., Jenkins S.G. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008, 29:966-968.
47. Valverde A., Grill F., Coque T.M., et al. High rate of intestinal colonization with extended-spectrum-β-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008, 46:2796-2799.
48. Rodríguez-Bãno J., López-Cerero L., Navarro M.D., Díaz de Alba P., Pascual A. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrobial Chemother 2008, 62:1142-1149.
49. Cotter M., Boyle F., Khan A., Boo T.W., O'Connell B. Dissemination of extended-spectrum β-lactamase-producing Escherichia coli at home: a potential occupational hazard for healthcare workers?. J Hosp Infect 2012, 80:100-101.
50. Advice on carbapenemase producers: recognition, infection control and treatment 2011, Health Protection Agency, Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection, London.
51. Gazin M., Paasch F., Goossens H., Malhotra-Kumar S. Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harbouring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2012, 50:1140-1146.
52. Warren R.E., Harvey G., Carr R., Ward D., Doroshenko A. Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community. Clin Microbiol Infect 2008, 14(Suppl. 1):124-133.
53. Siegel J.D., Rhinehart E., Jackson M., et al. Management of multidrug-resistant organisms in healthcare settings, 2006 2006, Healthcare Infection Control Practices Advisory Committee (HICPAC), Atlanta.
54. Casewell M., Phillips I. Hands as route of transmission for Klebsiella species. Br Med J 1977, 2:1315-1317.
55. Casewell M.W., Desai N. Survival of multiply-resistant Klebsiella aerogenes and other gram negative bacilli on finger tips. J Hosp Infect 1983, 4:350-360.
56. Sax H., Allegranzi B., Uçkay I., Larson E., Boyce J., Pittet D. 'My five moments for hand hygiene': a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 2007, 67:9-21.
57. Zahar J.R., Masse V., Watier L., et al. Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL)-acquired infections?. J Hosp Infect 2012, 80:348-350.
58. Menashe G., Borer A., Yagupsky P., et al. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. Scand J Infect Dis 2001, 33:188-193.
59. Lucet J.C., Chevret S., Decre D., et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996, 22:430-436.
60. Multi-resistant Gram negative bacilli (including ESBLs and acinetobacter) 2010, Infection Control Team, Ashford and St Peter's Hospital NHS Trust, Ashford.
61. Goddard S., Muller M.P. The efficacy of infection control interventions in reducing the incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the non-outbreak setting: a systematic review. Am J Infect Control 2011, 39:599-601.
62. Randrianirina F., Vedy S., Rakotovao D., et al. Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum β-lactamases. J Hosp Infect 2009, 72:23-29.
63. st century. Eur J Clin Microbiol Infect Dis 2011, 30:1473-1481.
64. Virgincar N., Iyer S., Stacey A., et al. Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK. J Hosp Infect 2011, 78:293-296.
65. Dancer S.J., White L.F., Lamb J., Girvan E.K., Robertson C. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Infect Med 2009, 7:28.
66. Rogawski ET, Harris A, Johnson JK, et al. Transfer of multidrug-resistant organisms to healthcare workers' gloves and gowns after patient contact increases with environmental contamination. Society for Healthcare Epidemiology of America, Atlanta, 2010. Poster no. 63.
67. Goodman E.R., Platt R., Bass R., Onderdonk A.B., Yokoe D.S., Huang S.S. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008, 29:593-599.
68. Thom K., Johnson J.K., Lee M.S., Harris A.D. Environmental decontamination because of multidrug-resistant Acinetobacter baumanii surrounding colonized or infected patients. Am J Infect Control 2011, 39:711-715.
69. Creamer E., Humphreys H. The contribution of beds to healthcare-associated infection: the importance of adequate decontamination. J Hosp Infect 2008, 69:8-23.
70. Ragan K., Khan A., Zeynalova N., McKernan P., Baser K., Muller M.P. Use of audit and feedback with fluorescent targeting to achieve rapid improvements in room cleaning in the intensive care unit and ward settings. Am J Infect Control 2012, 40:284-286.
71. Werry C., Lawrence J.M., Sanderson P.J. Contamination of detergent cleaning solutions during hospital cleaning. J Hosp Infect 1988, 11:44-49.
72. Medcraft J.W., Hawkins J.M., Fletcher B.N., Dadswell J.V. Potential hazard from spray cleaning of floors in hospital wards. J Hosp Infect 1987, 9:151-157.
73. Scott E., Bloomfield S.F. The survival and transfer of microbial contamination via cloths, hands and utensils. J Appl Bacteriol 1990, 68:271-278.
74. Dharan S., Mourouga P., Copin P., Bessmer G., Tschanz B., Pittet D. Routine disinfection of patients' environmental surfaces: myth or reality?. J Hosp Infect 1999, 42:113-117.
75. Moore G., Griffith C. A laboratory evaluation of the decontamination properties of microfibre cloths. J Hosp Infect 2006, 64:379-385.
76. Bergen L.K., Meyer M., Hog M., Rubenhagen B., Andersen L.P. Spread of bacteria on surfaces when cleaning with microfibre cloths. J Hosp Infect 2009, 71:132-137.
77. Dancer S.J. Mopping up hospital infection. J Hosp Infect 1999, 43:85-100.
78. Joynson D.H.M. Bowls and bacteria. J Hyg Cambr 1978, 80:423-425.
79. Engelhart S., Krizek L., Glasmacher A., Fischnaller E., Marklein G., Exner M. Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002, 52:93-98.
80. Forder A.A. Buckets and mops in operating theatres. Lancet 1973, 1:1325.
81. Wishart M.M., Riley T.V. Infection with Pseudomonas maltophilia: hospital outbreak due to contaminated disinfectant. Med J Aust 1976, 2:710-712.
82. McAllister T.A., Lucas C.E., Mocan H., et al. Serratia marcescens outbreak in a paediatric oncology unit traced to contaminated chlorhexidine. Scott Med J 1989, 34:525-528.
83. Naparstek L., Carmeli Y., Chmelnitsky I., Banen E., Navon-Venezia S. Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae. J Hosp Infect 2012, 81:15-19.
84. Pena C., Pujol M., Ricart A., et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997, 35:9-16.
85. Marchaim D., Taylor A.R., Hayakawa K., et al. Hospital bath basins are frequently contaminated with multi-drug-resistant human pathogens. Am J Infect Control 2011 Dec 15, [Epub ahead of print].
86. Maragakis L.L., Winkler A., Tucker M.G., et al. Outbreak of multidrug-resistant Serratia marcescens infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2008, 29:418-423.
87. Rutala W.A., Kennedy V.A., Loflin H.B., Sarubbi F.A. Serratia marcescens nosocomial infections of the urinary tract associated with urine measuring containers and urinometers. Am J Med 1981, 70:659-663.
88. Maltezou H.C., Tryfinopoulou K., Katerelos P., et al. Consecutive Serratia marcescens multiclone outbreaks in a nenonatal intensive care unit. Am J Infect Control 2012 Jan 19, [Epub ahead of print].
89. Shlaes C.I., Currie-McCumber E., Eanes M., Rotter G., Floyd R. Gentamicin-resistance plasmids in an intensive care unit. Infect Control 1986, 7:355-361.
90. Doring G., Ulrich M., Muller W., et al. Generation of Pseudomonas aeruginosa aerosols during hand-washing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentralbl Hyg 1991, 191:494-505.
91. Weber D.J., Rutala W.A., Blanchet C.N., Jordan M., Gergen M.F. Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia. Am J Infect Control 1999, 27:59-63.
92. Lucero C.A., Cohen A.L., Trevino I., et al. Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks. Am J Infect Control 2011, 39:775-778.
93. Hota S., Hirji Z., Stockton K., et al. Outbreak of multi-drug resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol 2009, 30:25-33.
94. Malnick S., Bardenstein R., Huszar M., Gabbay J., Borkow G. Pyjamas and sheets as a potential source of nosocomial pathogens. J Hosp Infect 2008, 70:89-92.
95. Meakin N.S., Bowman C., Lewis M.R., Dancer S.J. Comparison of cleaning efficacy between in-use disinfectant and electrolysed water in an English residential care home. J Hosp Infect 2012, 80:122-127.
96. Davies A., Pottage T., Bennett A., Walker J. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J Hosp Infect 2011, 77:199-203.
97. Mandal J., Kate A., Parija S.C. Microbicidal effect of electrolysed water. J Hosp Infect 2010, 76:94-95.
98. Boyle M.A., O'Donnell M.J., Miller A., Russell R.J., Coleman D.C. Control of bacterial contamination of washbasin taps and output water using Ecasol: a one-year study. J Hosp Infect 2012, 80:288-292.
99. An integrated approach to hospital cleaning: microfibre cloth and steam cleaning technology 2007, Department of Health, DoH, London.
100. Otter J.A., Yezli S., Schouten M.A., van Zanten A.R.H., Houmes-Zielman G., Nohlmans-Paulssen M.K.E. Hydrogen peroxide vapour decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant Gram-negative rods during an outbreak. Am J Infect Control 2010, 38:754-756.
101. Sharma M., Hudson J.B. Ozone gas is an effective and practical antibacterial agent. Am J Infect Control 2008, 36:559-563.
102. Maclean M., MacGregor S.J., Anderson J.G., et al. Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light. J Hosp Infect 2010, 76:247-251.
103. Page K., Wilson M., Parkin I.P. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem 2009, 19:3819-3831.
104. Song L., Wu J., Xi C. Biofilms on environmental surfaces: evaluation of the disinfection efficacy of a novel steam vapor system. Am J Infect Control 2012 Mar 12, [Epub ahead of print].
105. Sattar S.A. Promises and pitfalls of recent advances in chemical means of preventing the spread of nosocomial infections by environmental surfaces. Am J Infect Control 2010, 38:S34-S40.
106. Alfa M.J., Lo E., Wald A., Dueck C., DeGagne P., Harding G.K. Improved eradication of Clostridium difficile spores from toilets of hospitalized patients using an accelerated hydrogen peroxide as the cleaning agent. BMC Infect Dis 2010, 10:268.
107. Airey P., Vernan J. Potential use of copper as a hygienic surface; problems associated with cumulative soiling and cleaning. J Hosp Infect 2007, 67:271-277.
108. Touati A., Zenati K., Brasma L., Benallaoua S., deChamps C. Extended-spectrum beta-lactamase characterization and heavy metal resistance of Enterobacteriaceae strains isolated from hospital environmental surfaces. J Hosp Infect 2010, 75:78-79.
109. Paterson D.L., Singh N., Rihs J.D., et al. Control of an outbreak of infection due to extended-spectrum beta-lactamase-producing Escherichia coli in a liver transplantation unit. Clin Infect Dis 2001, 33:126-128.
110. Buehlmann M., Bruderer T., Frei R., et al. Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae. J Hosp Infect 2011, 77:113-117.
111. Zuckerman T., Benyamini N., Sprecher H., et al. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant 2011, 46:1226-1230.
112. Stoutenbeek C.P., van Saene H.K.F., Little R.A., Whitehead A. The effect of selective decontamination of the digestive tract on mortality in multiple trauma patients; a multicentre randomized controlled trial. Intensive Care Med 2007, 33:261-270.
113. Avorn J.L., Barrett J.F., Davey P.G., McEwen S.A., O'Brien T.F., Levy S.B. Alliance for the Prudent Use of Antibiotics 2001, World Health Organization: WHO/CDS/CSR/DRS/2001.10, Antibiotic resistance: synthesis of recommendations by expert policy groups. p. 1-155.
114. Davey P., Brown E., Fenelon L., et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005, (4):CD003543.
115. Ansari F., Erntell M., Goossens H., Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009, 49:1496-1504.
116. Willemsen I., Groenhuijzen A., Bogaers D., Tuurman A., van Keulen P., Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 2007, 51:864-867.
117. Lo W.-U., Ho P.-L., Chow K.-H., Lai E.L., Yeung F., Chiu S.S. Faecal carriage of CTXM type extended-spectrum β-lactamase-producing organisms by children and their household contacts. J Infect 2010, 60:286-292.
118. Luvsansharav U.-O., Hirai I., Niki M., et al. Analysis of risk factors for a high prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand. J Med Microbiol 2011, 60:619-624.
119. Dancer S.J. The problem with cephalosporins. J Antimicrob Chemother 2001, 48:463-478.
120. Findlay J., Hamouda A., Dancer S.J., Amyes S.G. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy. Clin Microbiol Infect 2012, 18:140-146.
121. Giamarellou H. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents 2010, 36(Suppl. 2):S50-S54.
122. Ma M., Goldstein E.J.C., Friedman M.H., Anderson M.S., Mulligan M.E. Resistance of Gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother 1983, 24:347-352.
123. Carling P., Fung T., Killion A., Terrin N., Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003, 24:699-706.
124. Stockley J.M. European Antibiotic Awareness Day 2010: why doesn't promoting antibiotic awareness always work?. J Infect 2010, 61:361-363.
125. Beardsley J.R., Williamson J.C., Johnson J.W., Ohl C.A., Karchmer T.B., Bowton D.L. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006, 130:787-793.
126. Chastre J., Wolff M., Fagon J.Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003, 290:2588-2598.
127. Hand K. Antibiotic pharmacists in the ascendancy. J Antimicrob Chemother 2007, 60(Suppl. 1):i73-i76.
128. Takesue Y., Nakajima K., Ichiki K., et al. Impact of a hospital-wide antibiotic-resistant Gram-negative bacteria. J Hosp Infect 2010, 75:28-32.
129. Breteler B., Rentenaar R.J., Verkaart G., Sturm P.D. Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients. Scand J Infect Dis 2011, 43:771-776.
130. Ciobotaro P., Oved M., Nadir E., Bardenstein R., Zimhony O. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011, 39:671-677.
131. Lowe C., Katz K., McGeer A., Muller P. Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control 2012 Feb 21, [Epub ahead of print].